NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis $9.57 -0.28 (-2.84%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$9.50▼$9.9050-Day Range$7.90▼$10.1052-Week Range$5.01▼$10.75Volume1,077 shsAverage Volume2,605 shsMarket Capitalization$12.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get Guardion Health Sciences alerts: Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Guardion Health Sciences Stock (NASDAQ:GHSI)Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More GHSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GHSI Stock News HeadlinesMay 31, 2024 | globenewswire.comGuardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and DissolutionMay 24, 2024 | finanznachrichten.deGuardion Health Sciences, Inc.: Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv BusinessJuly 27, 2024 | True Market Insiders (Ad)Amazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…May 23, 2024 | globenewswire.comGuardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv BusinessMay 21, 2024 | finance.yahoo.comGuardion Health Sciences Announces its Largest Stockholder Has Voted in Favor of Proposals to Sell the Viactiv Business and the Liquidation Plan at the Company’s Special Meeting of Stockholders to be held on May 23, 2024May 13, 2024 | investorplace.comGHSI Stock Earnings: Guardion Health Sciences Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | globenewswire.comGuardion Health Sciences AnnouncesApril 27, 2024 | msn.comThe Hunger Project Ghana, GHS commemorate World Malaria DayJuly 27, 2024 | True Market Insiders (Ad)Amazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…April 17, 2024 | morningstar.comGuardion Health Sciences Inc GHSIApril 15, 2024 | finance.yahoo.comGuardion Health Sciences, Inc. (GHSI)April 9, 2024 | msn.comMolecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare moversApril 4, 2024 | msn.comAccess Bank Ghana makes historic GHS One billion plus profit before taxApril 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth WatchingMarch 29, 2024 | markets.businessinsider.comGuardion Health Swings To Annual Net Profit, Revenue ImprovesMarch 29, 2024 | globenewswire.comGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023March 28, 2024 | finance.yahoo.comGHS Label Market Set to Achieve Steady Growth with a 3.4% CAGR through 2034 | Future Market Insights Inc.February 24, 2024 | msn.comGuardion Health Sciences (GHSI) Price Target Increased by 233.33% to 40.80See More Headlines Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GHSI CUSIPN/A CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees10Year Founded2009Profitability EPS (Most Recent Fiscal Year)($4.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$160,000.00 Net Margins-16.69% Pretax Margin-16.69% Return on Equity-77.29% Return on Assets-42.08% Debt Debt-to-Equity RatioN/A Current Ratio8.17 Quick Ratio6.49 Sales & Book Value Annual Sales$12.25 million Price / Sales1.00 Cash Flow$0.14 per share Price / Cash Flow70.01 Book Value$6.39 per share Price / Book1.50Miscellaneous Outstanding Shares1,280,000Free Float1,267,000Market Cap$12.25 million OptionableNot Optionable Beta0.91 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Robert Neal Weingarten (Age 72)Independent Chairman & Secretary Comp: $110kMs. Janet Hall (Age 65)President & CEO Comp: $704.85kMs. Katie Cox (Age 54)Chief Accounting Officer Comp: $275kMr. Craig J. Sheehan (Age 53)Chief Commercial Officer Comp: $457.5kKey CompetitorsImunonNASDAQ:CLSNKezar Life SciencesNASDAQ:KZRDyadic InternationalNASDAQ:DYAILakeshore BiopharmaNASDAQ:LSBYS BiopharmaNASDAQ:YSView All Competitors GHSI Stock Analysis - Frequently Asked Questions How have GHSI shares performed this year? Guardion Health Sciences' stock was trading at $5.34 at the beginning of 2024. Since then, GHSI shares have increased by 79.2% and is now trading at $9.57. View the best growth stocks for 2024 here. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings data on Monday, May, 13th. The company reported ($3.71) EPS for the quarter. The business earned $3 million during the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 77.29% and a negative net margin of 16.69%. When did Guardion Health Sciences' stock split? Shares of Guardion Health Sciences reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. How do I buy shares of Guardion Health Sciences? Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO) and Ocugen (OCGN). This page (NASDAQ:GHSI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardion Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.